» Articles » PMID: 37073850

[Recent Research on Childhood Hypertrophic Cardiomyopathy Caused by Gene Mutations]

Overview
Specialty Pediatrics
Date 2023 Apr 19
PMID 37073850
Authors
Affiliations
Soon will be listed here.
Abstract

Hypertrophic cardiomyopathy (HCM) is the most common monogenic inherited myocardial disease in children, and mutations in sarcomere genes (such as and ) are the most common genetic etiology of HCM, among which mutations in the gene are the most common and account for 30%-50%. gene mutations have the characteristics of being affected by environmental factors, coexisting with multiple genetic variations, and age-dependent penetrance, which leads to different or overlapping clinical phenotypes in children, including various cardiomyopathies and skeletal myopathies. At present, the pathogenesis, course, and prognosis of HCM caused by gene mutations in children remain unclear. This article summarizes the possible pathogenesis, clinical phenotype, and treatment of HCM caused by gene mutations, in order to facilitate the accurate prognostic evaluation and individualized management and treatment of the children with this disorder.

Citing Articles

Pathogenic genes and clinical prognosis in hypertrophic cardiomyopathy.

Hong Y, Xi H, Yang X, Su W, Li X World J Cardiol. 2025; 17(1):99595.

PMID: 39866219 PMC: 11755131. DOI: 10.4330/wjc.v17.i1.99595.


Risk Assessment and Personalized Treatment Options in Inherited Dilated Cardiomyopathies: A Narrative Review.

Arnautu D, Cozma D, Lala I, Arnautu S, Tomescu M, Andor M Biomedicines. 2024; 12(8).

PMID: 39200108 PMC: 11351202. DOI: 10.3390/biomedicines12081643.


Comprehensive review on gene mutations contributing to dilated cardiomyopathy.

Wang S, Zhang Z, He J, Liu J, Guo X, Chu H Front Cardiovasc Med. 2023; 10:1296389.

PMID: 38107262 PMC: 10722203. DOI: 10.3389/fcvm.2023.1296389.


[Phenotype and genotype characteristics of children with cardiomyopathy associated with gene mutation: a retrospective analysis].

Liu L, Zheng K, Zhang Y Zhongguo Dang Dai Er Ke Za Zhi. 2023; 25(11):1156-1160.

PMID: 37990461 PMC: 10672950. DOI: 10.7499/j.issn.1008-8830.2306108.


[Clinical and genetic characteristics of children with primary dilated cardiomyopathy].

Zheng K, Wu F, Lou M, Wang Y, Li B, Hao J Zhongguo Dang Dai Er Ke Za Zhi. 2023; 25(7):726-731.

PMID: 37529955 PMC: 10414173. DOI: 10.7499/j.issn.1008-8830.2303077.

References
1.
Walsh R, Rutland C, Thomas R, Loughna S . Cardiomyopathy: a systematic review of disease-causing mutations in myosin heavy chain 7 and their phenotypic manifestations. Cardiology. 2009; 115(1):49-60. DOI: 10.1159/000252808. View

2.
Yotti R, Seidman C, Seidman J . Advances in the Genetic Basis and Pathogenesis of Sarcomere Cardiomyopathies. Annu Rev Genomics Hum Genet. 2019; 20:129-153. DOI: 10.1146/annurev-genom-083118-015306. View

3.
Hershkovitz T, Kurolap A, Ruhrman-Shahar N, Monakier D, Dechene E, Peretz-Amit G . Clinical diversity of MYH7-related cardiomyopathies: Insights into genotype-phenotype correlations. Am J Med Genet A. 2018; 179(3):365-372. DOI: 10.1002/ajmg.a.61017. View

4.
Herrera-Rodriguez D, Totomoch-Serra A, Rosas-Madrigal S, Luna-Limon C, Marroquin-Ramirez D, Carnevale A . Genes frequently associated with sudden death in primary hypertrophic cardiomyopathy. Arch Cardiol Mex. 2020; 90(1):58-68. DOI: 10.24875/ACM.19000294. View

5.
Shahzadi S, Naidoo N, Alsheikh-Ali A, Rizzo M, Rizvi A, Santos R . Reconnoitering the Role of Long-Noncoding RNAs in Hypertrophic Cardiomyopathy: A Descriptive Review. Int J Mol Sci. 2021; 22(17). PMC: 8430576. DOI: 10.3390/ijms22179378. View